S. Constantine

Ataluren (PTC124) Induces Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression and Activity in Children with Nonsense Mutation Cystic Fibrosis

Isabelle Sermet‐Gaudelus, K. De Boeck, Georges Casimir et al. · American Journal of Respiratory and Critical Care Medicine · 2010 · 240 citations

Medicine, Pediatrics, Pharmacology +16

Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo‐Controlled Trial in Adults With Systemic Sclerosis

Robert Spiera, Laura K. Hummers, Tracy Frech et al. · Arthritis & Rheumatology · 2020 · 104 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosis

James F. Chmiel, Patrick A. Flume, D.G. Downey et al. · Journal of Cystic Fibrosis · 2020 · 68 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +6

Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial

Victoria P. Werth, Emily Z. Hejazi, S.M. Peña et al. · Journal of Investigative Dermatology · 2022 · 53 citations · Full text

Medicine, Dermatology, Pharmacology +12

Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis

Robert Spiera, Masataka Kuwana, Dinesh Khanna et al. · Arthritis & Rheumatology · 2023 · 43 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13